Computed tomography: revolutionizing the practice of medicine for 40 years

GD Rubin - Radiology, 2014 - pubs.rsna.org
Computed tomography (CT) has had a profound effect on the practice of medicine. Both the
spectrum of clinical applications and the role that CT has played in enhancing the depth of …

Hybrid imaging (SPECT/CT and PET/CT)—improving the diagnostic accuracy of functional/metabolic and anatomic imaging

E Even-Sapir, Z Keidar, R Bar-Shalom - Seminars in nuclear medicine, 2009 - Elsevier
In-line combined systems, single-photon emission computed tomography
(SPECT)/computed tomography (CT) and positron emission tomography (PET)/CT, allow an …

Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer

D Groheux, E Hindié, M Delord… - Journal of the …, 2012 - academic.oup.com
Background This study prospectively evaluated the yield of fluorodeoxyglucose positron
emission tomography/computed tomography (18FDG-PET-CT) in patients with clinical …

Bone Metastases in Patients with Metastatic Breast Cancer: Morphologic and Metabolic Monitoring of Response to Systemic Therapy with Integrated PET/CT1

U Tateishi, C Gamez, S Dawood, HWD Yeung… - Radiology, 2008 - pubs.rsna.org
Purpose: To retrospectively compare morphologic and metabolic changes in bone
metastases in response to systemic therapy in patients with metastatic breast cancer (MBC) …

Fusion of Metabolic Function and Morphology: Sequential [18F]Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Studies Yield New …

Y Du, I Cullum, TM Illidge, PJ Ell - Journal of clinical oncology, 2007 - ascopubs.org
Purpose By monitoring bone metastases with sequential [18F] fluorodeoxyglucose positron-
emission tomography/computed tomography ([18F] FDG-PET/CT) imaging, this study …

Bone involvement in patients with lymphoma: the role of FDG-PET/CT

NG Schaefer, K Strobel, C Taverna, TF Hany - European journal of nuclear …, 2007 - Springer
Purpose To evaluate the diagnostic impact and clinical significance of FDG-avid bone
lesions detected by FDG-PET/CT in patients with lymphoma. Methods The study population …

The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study

D Groheux, S Giacchetti, M Espié… - Journal of Nuclear …, 2011 - Soc Nuclear Med
The purpose of this study was to prospectively evaluate the role of 18F-FDG PET/CT in
patients with stage IIA, IIB, or IIIA breast cancer. Methods: During 56 mo, 131 consecutive …

The clinical efficacy of 18F-FDG-PET/CT in benign and malignant musculoskeletal tumors

DS Shin, OJ Shon, DS Han, JH Choi, KA Chun… - Annals of nuclear …, 2008 - Springer
Objective Most of the current clinical data on the role of 2-[18 F] fluoro-2-deoxy-d-glucose
positron emission tomography (18 F-FDG-PET) in musculoskeletal tumors come from …

Detection of Bone Metastases: Assessment of Integrated FDG PET/CT Imaging1

AV Taira, RJ Herfkens, SS Gambhir, A Quon - Radiology, 2007 - pubs.rsna.org
Purpose: To retrospectively evaluate the positive predictive value (PPV) of fluorine 18
fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) …

18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers

N Withofs, B Grayet, T Tancredi, A Rorive… - Nuclear medicine …, 2011 - journals.lww.com
Objective To evaluate the accuracy of 18 F-fluoride PET/computed tomography (CT) to
detect bone metastases (BMs) in a breast and prostate cancer population, using magnetic …